JP2018203733A5 - - Google Patents

Download PDF

Info

Publication number
JP2018203733A5
JP2018203733A5 JP2018103970A JP2018103970A JP2018203733A5 JP 2018203733 A5 JP2018203733 A5 JP 2018203733A5 JP 2018103970 A JP2018103970 A JP 2018103970A JP 2018103970 A JP2018103970 A JP 2018103970A JP 2018203733 A5 JP2018203733 A5 JP 2018203733A5
Authority
JP
Japan
Prior art keywords
group
formula
optionally substituted
compound represented
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018103970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018203733A (ja
JP7102233B2 (ja
Filing date
Publication date
Priority claimed from PCT/IB2018/053822 external-priority patent/WO2018220533A2/ja
Application filed filed Critical
Publication of JP2018203733A publication Critical patent/JP2018203733A/ja
Publication of JP2018203733A5 publication Critical patent/JP2018203733A5/ja
Priority to JP2022078462A priority Critical patent/JP7420865B2/ja
Application granted granted Critical
Publication of JP7102233B2 publication Critical patent/JP7102233B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018103970A 2017-05-30 2018-05-30 光学活性化合物の製造法 Active JP7102233B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022078462A JP7420865B2 (ja) 2017-05-30 2022-05-11 光学活性化合物の製造法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2017106280 2017-05-30
JP2017106280 2017-05-30
PCT/IB2018/053822 WO2018220533A2 (ja) 2017-05-30 2018-05-29 光学活性化合物の製造法
WOPCT/IB2018/053822 2018-05-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022078462A Division JP7420865B2 (ja) 2017-05-30 2022-05-11 光学活性化合物の製造法

Publications (3)

Publication Number Publication Date
JP2018203733A JP2018203733A (ja) 2018-12-27
JP2018203733A5 true JP2018203733A5 (enExample) 2021-07-26
JP7102233B2 JP7102233B2 (ja) 2022-07-19

Family

ID=64454503

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018103970A Active JP7102233B2 (ja) 2017-05-30 2018-05-30 光学活性化合物の製造法
JP2022078462A Active JP7420865B2 (ja) 2017-05-30 2022-05-11 光学活性化合物の製造法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022078462A Active JP7420865B2 (ja) 2017-05-30 2022-05-11 光学活性化合物の製造法

Country Status (12)

Country Link
US (2) US10988469B2 (enExample)
EP (2) EP3632441B1 (enExample)
JP (2) JP7102233B2 (enExample)
KR (1) KR102754527B1 (enExample)
CN (2) CN117447464A (enExample)
AU (1) AU2018276192B2 (enExample)
CA (1) CA3065683A1 (enExample)
EA (1) EA039880B1 (enExample)
ES (1) ES2986461T3 (enExample)
IL (1) IL270983B (enExample)
MX (1) MX391164B (enExample)
WO (1) WO2018220533A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102754527B1 (ko) 2017-05-30 2025-01-14 데이 원 바이오파마슈티칼즈, 인크. 광학 활성 화합물의 제조법
EP3950672A4 (en) * 2019-03-27 2023-01-11 Kyowa Pharma Chemical Co., Ltd. PROCESS FOR PRODUCTION OF PROSTAGLANDIN
AU2021376286A1 (en) * 2020-11-06 2023-06-22 Dana-Farber Cancer Institute, Inc. Raf inhibitor for treating low grade glioma
CN114685564B (zh) * 2020-12-27 2023-09-22 西北大学 新型亚磷酰胺配体及其合成方法和应用
CN117715889A (zh) 2021-07-26 2024-03-15 阿尔维纳斯运营股份有限公司 制备双官能化合物的方法
CN117567388B (zh) * 2023-11-14 2024-04-16 济南悟通生物科技有限公司 一种2-乙酰基-5-噻唑甲酸的合成方法
CN119241530A (zh) * 2024-09-20 2025-01-03 武汉九州钰民医药科技有限公司 一种Tovorafenib的药物合成工艺
CN119241529A (zh) * 2024-09-20 2025-01-03 武汉九州钰民医药科技有限公司 一种Tovorafenib的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764842B2 (en) * 2001-03-28 2004-07-20 Merck & Co., Inc. Enantioselective bioreduction for the preparation of integrin receptor antagonist intermediates
TW200303304A (en) 2002-02-18 2003-09-01 Astrazeneca Ab Chemical compounds
MY139887A (en) * 2004-04-02 2009-11-30 Mitsubishi Tanabe Pharma Corp Tetrahydronaphthyridine derivatives and a process for preparing the same.
CA2694284A1 (en) * 2007-06-29 2009-01-08 Jennifer Cossrow Heterocyclic compounds useful as raf kinase inhibitors
TWI444379B (zh) 2007-06-29 2014-07-11 Sunesis Pharmaceuticals Inc 有用於作為Raf激酶抑制劑之化合物
EP3680240A1 (en) * 2012-03-14 2020-07-15 Merck Sharp & Dohme Corp. Asymmetric phase transfer catalysis
WO2013146987A1 (ja) 2012-03-28 2013-10-03 武田薬品工業株式会社 ロジウム触媒及びアミン化合物の製造法
TWI602803B (zh) * 2013-03-29 2017-10-21 第一三共股份有限公司 光學活性二胺衍生物之製造方法
WO2015178846A1 (en) * 2014-05-20 2015-11-26 Sp Process Development Ab Process for the preparation of chiral amines from prochiral ketones
JP6638363B2 (ja) 2015-12-11 2020-01-29 株式会社大林組 掘削装置および杭孔の拡径方法
CN105524111B (zh) * 2016-01-25 2017-10-27 西北农林科技大学 手性亚磷酰胺单齿配体及其合成方法与应用
KR102754527B1 (ko) 2017-05-30 2025-01-14 데이 원 바이오파마슈티칼즈, 인크. 광학 활성 화합물의 제조법

Similar Documents

Publication Publication Date Title
JP2018203733A5 (enExample)
JP2004511590A5 (enExample)
TWI297687B (en) Linezolid-crystal form ii
CA2501314A1 (en) Methods for preparing n-arylated oxazolidinones via a copper catalyzed cross coupling reaction
JP2009523146A5 (enExample)
JP2006520417A5 (enExample)
CN1768944A (zh) 一种以膦-亚磷酰胺酯为配体的催化剂及制法和应用
KR950702537A (ko) 키랄[[(2-브로모에틸)아미노]메틸]-2-니트로-1H-이미디졸-1-에탄올 및 관련화합물의 신규 제조 방법(Novel Process for preparing Chiral [[(2-Bromoethyl)aminomethyl]-2-nitro-1H-imidazol-1-ethanol and Related Compounds)
JP2010505861A5 (enExample)
JP2006518788A5 (enExample)
JP2006526587A5 (enExample)
Schattenmann et al. Synthesis of zirconium complexes that contain a tridentate diamido ligand
ES2465003T3 (es) Procesos para la producción de compuestos amido e imido metálico de transición
Bani-Fwaz et al. Crystal structures and quantum chemical calculations of dichloro [4-(dimethylamino) phenyl] arsine and tris [4-(dimethylamino) phenyl] arsine
JP2001064290A (ja) 新規なアミノホスホニウム化合物
JP2010512379A5 (enExample)
JPS5892688A (ja) 亜ホスホン酸の製造法
JP2023513187A (ja) 2-(4-フルオロ-3-(トリフルオロメチル)フェノキシ)ブタン酸を分割することによるs-ベフルブタミドの調製
JPH0228598B2 (enExample)
JP2009528320A5 (enExample)
JPWO2021085535A5 (enExample)
JP2002523479A5 (enExample)
JP2008526940A5 (enExample)
JPWO2022226408A5 (enExample)
JPH04295440A (ja) 不整水素添加